Table 1 Clinical characteristics of the residents who completed the follow-up
Baseline characteristics | Residents who were known CPE carriers n = 6 (%) | Residents who were not known to carry CPE n = 26 (%) | Total n = 32 (%) | Fisher’s exact test |
|---|---|---|---|---|
Age, Median (IQR) | 71 (56–78) | 78 (72–92) | 77 (69–90) | 0.11a |
Gender, Female | 6 (100.00) | 21 (80.77) | 27 (84.38) | 0.56 |
Comorbidities | Â | Â | Â | Â |
Chronic obstructive pulmonary disease | 0 (0.00) | 3 (11.54) | 3 (9.38) | 1.00 |
Cardiovascular disease | 1 (16.67) | 6 (23.08) | 7 (21.88) | 1.00 |
Chronic neurological disease | 5 (83.33) | 19 (73.08) | 24 (75.00) | 1.00 |
Malignant disease | 1 (16.67) | 3 (11.54) | 4 (12.50) | 1.00 |
Chronic kidney disease | 0 (0.00) | 5 (19.23) | 5 (15.63) | 0.56 |
Diabetes Mellitus | 1 (16.67) | 5 (19.23) | 6 (18.75) | 1.00 |
Chronic liver disease | 0 (0.00) | 1 (3.85) | 1 (3.13) | 1.00 |
Ambulatory status | Â | Â | Â | Â |
Ambulant with or without assistance | 0 (0.00) | 3 (11.54) | 3 (9.38) | 0.30 |
Ambulant with wheel-chair | 4 (66.67) | 20 (76.92) | 24 (75.00) | |
Bedbound | 2 (33.33) | 3 (11.54) | 5 (15.63) | |
Invasive procedures at baseline | Â | Â | Â | Â |
Nasogastric tube | 3 (50.00) | 2 (7.69) | 5 (15.63) | 0.03 |
Indwelling urinary catheter | 1 (16.67) | 1 (3.85) | 2 (6.25) | 0.35 |
Central line | 0 (0.00) | 0 (0.00) | 0 (0.00) | Not applicable |
Medications at baseline | Â | Â | Â | Â |
Antibiotics in the past 30 days | 3 (50.00) | 2 (7.69) | 5 (15.63) | 0.03 |
Proton pump inhibitors in the past 30 days | 3 (50.00) | 9 (34.62) | 12 (37.50) | 0.65 |